Abstract
Background and Objective:
Although there is strong evidence linking obesity with increased sympathoneural activity, involvement of the adrenal medulla is less clear. We therefore investigated adrenal medullary function under fasting and feeding conditions in normal weight (NW, n=33), overweight (OW, n=28) and obese (OB, n=36) adults (59% women).
Subjects and Methods:
Ninety-seven healthy adults participated in a cross-sectional study with recruitment stratified according to BMI. Plasma for catecholamines and metanephrines was sampled in the fasting state, at 30-min intervals during a 120-min glucose tolerance test and during an euglycaemic-hyperinsulinaemic clamp (40 mU m−2 min−1 insulin dose). Body composition was determined by leg-to-leg bioelectrical impedance analysis.
Results:
Obese subjects had the lowest fasting plasma concentrations of epinephrine (NW: 0.17, 95% confidence interval (CI): 0.14–0.20 nmol l−1; OW: 0.16, 95% CI: 0.12–0.19 nmol l−1; OB: 0.11, 95% CI: 0.08–0.13 nmol l−1; P=0.018) and metanephrine (NW: 0.17, 95% CI: 0.15–0.19 nmol l−1; OW: 0.15, 95% CI: 0.13–0.16 nmol l−1; OB: 0.13, 95% CI: 0.12–0.15 nmol l−1; P=0.022), the latter reflecting adrenal medullary store size. Fasting plasma epinephrine (r=−0.437; P<0.001) and metanephrine (r=−0.477; P<0.001) concentrations were additionally inversely correlated with whole-body fat percentage. Suppression of epinephrine secretion in response to carbohydrate ingestion was significantly blunted in overweight and obese subjects compared with the normal weight subjects (Pinteraction=0.045). Most of the variance in basal epinephrine was related to whole-body fat percentage (β=−0.389, 95% CI: −0.09 to −0.69; P=0.012) that explained the lower concentrations of epinephrine and metanephrine in women than men.
Conclusions:
We provide evidence that adrenomedullary dysfunction is a characteristic feature of obesity that involves both reduced adrenal secretion of epinephrine and size of adrenal medullary epinephrine stores.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cryer PE . Adrenaline: a physiological metabolic regulatory hormone in humans? Int J Obes Relat Metab Disord 1993; 17: S43–S46.
Eikelis N, Esler M . The neurobiology of human obesity. Exp Physiol 2005; 90: 673–682.
Landsberg L, Young JB . The role of the sympathoadrenal system in modulating energy expenditure. Clin Endocrinol Metab 1984; 13: 475–499.
Goldstein DS . Differential responses of components of the autonomic nervous system. Handb Clin Neurol 2013; 117: 13–22.
Robertson D, Johnson GA, Robertson RM, Nies AS, Shand DG, Oates JA . Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man. Circulation 1979; 59: 637–643.
Patel JN, Eisenhofer G, Coppack SW, Miles JM . Norepinephrine spillover in forearm and subcutaneous adipose tissue before and after eating. J Clin Endocrinol Metab 1999; 84: 2815–2819.
Penev P, Spiegel K, Marcinkowski T, Van Cauter E . Impact of carbohydrate-rich meals on plasma epinephrine levels: dysregulation with aging. J Clin Endocrinol Metab 2005; 90: 6198–6206.
Esler M, Straznicky N, Eikelis N, Masuo K, Lambert G, Lambert E . Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 2006; 48: 787–796.
Straznicky NE, Lambert GW, Masuo K, Dawood T, Eikelis N, Nestel PJ et al. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome. Am J Clin Nutr 2009; 89: 27–36.
Lambert E, Sari CI, Dawood T, Nguyen J, McGrane M, Eikelis N et al. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension 2010; 56: 351–358.
Jones PP, Davy KP, Seals DR . Relations of total and abdominal adiposity to muscle sympathetic nerve activity in healthy older males. Int J Obes Relat Metab Disord 1997; 21: 1053–1057.
Grassi G, Facchini A, Trevano FQ, Dell'Oro R, Arenare F, Tana F et al. Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension 2005; 46: 321–325.
Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK . Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 1998; 98: 772–776.
Seravalle G, Colombo M, Perego P, Giardini V, Volpe M, Dell'Oro R et al. Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients. Hypertension 2014; 64: 431–437.
Lambert EA, Straznicky NE, Lambert GW . A sympathetic view of human obesity. Clin Auton Res 2013; 23: 9–14.
Lambert GW, Straznicky NE, Lambert EA, Dixon JB, Schlaich MP . Sympathetic nervous activation in obesity and the metabolic syndrome—causes, consequences and therapeutic implications. Pharmacol Ther 2010; 126: 159–172.
Sowers JR, Whitfield LA, Catania RA, Stern N, Tuck ML, Dornfeld L et al. Role of the sympathetic nervous system in blood pressure maintenance in obesity. J Clin Endocrinol Metab 1982; 54: 1181–1186.
Bryde Andersen H, Raben A, Astrup A, Christensen NJ . Plasma adrenaline concentration is lower in post-obese than in never-obese women in the basal state, in response to sham-feeding and after food intake. Clin Sci 1994; 87: 69–74.
Del Rio G . Adrenomedullary function and its regulation in obesity. Int J Obes Relat Metab Disord 2000; 24: S89–S91.
Lee ZS, Critchley JA, Tomlinson B, Young RP, Thomas GN, Cockram CS et al. Urinary epinephrine and norepinephrine interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese. Metabolism 2001; 50: 135–143.
Peterson HR, Rothschild M, Weinberg CR, Fell RD, McLeish KR, Pfeifer MA . Body fat and the activity of the autonomic nervous system. N Engl J Med 1988; 318: 1077–1083.
Eisenhofer G, Rundquist B, Aneman A, Friberg P, Dakak N, Kopin IJ et al. Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines. J Clin Endocrinol Metab 1995; 80: 3009–3017.
[No authors listed]. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. 2000. World Health Organ Tech Rep Ser 2000; 894, i–xii, 1–253.
Jebb SA, Cole TJ, Doman D, Murgatroyd PR, Prentice AM . Evaluation of the novel Tanita body-fat analyser to measure body composition by comparison with a four-compartment model. Br J Nutr 2000; 83: 115–122.
Jebb SA, Siervo M, Murgatroyd PR, Evans S, Fruhbeck G, Prentice AM . Validity of the leg-to-leg bioimpedance to estimate changes in body fat during weight loss and regain in overweight women: a comparison with multi-compartment models. Int J Obes 2007; 31: 756–762.
DeFronzo RA, Tobin JD, Andres R . Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214–E223.
Eisenhofer G, Goldstein DS, Stull R, Keiser HR, Sunderland T, Murphy DL et al. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem 1986; 32: 2030–2033.
Peitzsch M, Prejbisz A, Kroiss M, Beuschlein F, Arlt W, Januszewicz A et al. Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma. Ann Clin Biochem 2013; 50: 147–155.
Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH . Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003; 28: 916–931.
Reims HM, Fossum E, Hoieggen A, Moan A, Eide I, Kjeldsen SE . Adrenal medullary overactivity in lean, borderline hypertensive young men. Am J Hypertens 2004; 17: 611–618.
Young JB, Rosa RM, Landsberg L . Dissociation of sympathetic nervous system and adrenal medullary responses. Am J Physiol 1984; 247: E35–E40.
Young JB, Macdonald IA . Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980. Int J Obes Relat Metab Disord 1992; 16: 959–967.
Okamura T, Nakajima Y, Satoh T, Hashimoto K, Sapkota S, Yamada E et al. Changes in visceral and subcutaneous fat mass in patients with pheochromocytoma. Metabolism 2015; 64: 706–712.
Petrak O, Haluzikova D, Kavalkova P, Strauch B, Rosa J, Holaj R et al. Changes in energy metabolism in pheochromocytoma. J Clin Endocrinol Metab 2013; 98: 1651–1658.
Eisenhofer G, Friberg P, Pacak K, Goldstein DS, Murphy DL, Tsigos C et al. Plasma metadrenalines: do they provide useful information about sympatho-adrenal function and catecholamine metabolism? Clin Sci 1995; 88: 533–542.
Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G . Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev 1990; 70: 963–985.
Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S et al. The sympathetic nervous system and the metabolic syndrome. J Hypertens 2007; 25: 909–920.
Trunet P, Lhoste F, Ansquer JC, Kestenbaum S, Sabatier C, Tillement JP et al. Decreased plasma epinephrine concentrations after glucose ingestion in humans. Metabolism 1984; 33: 101–103.
Davidson L, Vandongen R, Rouse IL, Beilin LJ, Tunney A . Sex-related differences in resting and stimulated plasma noradrenaline and adrenaline. Clin Sci 1984; 67: 347–352.
Eisenhofer G, Lattke P, Herberg M, Siegert G, Qin N, Darr R et al. Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma. Ann Clin Biochem 2013; 50: 62–69.
Lehmann M, Keul J . Urinary excretion of free noradrenaline and adrenaline related to age, sex and hypertension in 265 individuals. Eur J Appl Physiol Occup Physiol 1986; 55: 14–18.
Hinojosa-Laborde C, Chapa I, Lange D, Haywood JR . Gender differences in sympathetic nervous system regulation. Clin Exp Pharmacol Physiol 1999; 26: 122–126.
Acknowledgements
We are grateful to all volunteers for their participation. We thank B Kindel and K Haink for their kind technical assistance. We express our gratitude to J Viehweg, K Löbmann and A Kästner for their support in the study organisation and recruitment. This study was supported by the University Hospital Carl Gustav Carus and the German Diabetes Foundation (271-07-10).
Author contributions
MR is responsible for the study design, general supervision, data collection, analysis and interpretation of data and drafting of the article. TZ is the responsible study clinician and contributed to the study design, data analysis and interpretation. MG and SRB were involved in the medical supervision and data acquisition. GE, CK and NQ contributed to data analysis and interpretation. GE was involved in the discussion and comprehensively revised/edited the paper before submission. All authors gave final approval of the current version to be published. MR is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on International Journal of Obesity website
Supplementary information
Rights and permissions
About this article
Cite this article
Reimann, M., Qin, N., Gruber, M. et al. Adrenal medullary dysfunction as a feature of obesity. Int J Obes 41, 714–721 (2017). https://doi.org/10.1038/ijo.2017.36
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2017.36
This article is cited by
-
Changes in the Expression of Transcription Factor Oct4 during Postnatal Development of Adrenal Medulla
Bulletin of Experimental Biology and Medicine (2022)
-
Effect of black ginseng and silkworm supplementation on obesity, the transcriptome, and the gut microbiome of diet-induced overweight dogs
Scientific Reports (2021)
-
HIF2α regulates the synthesis and release of epinephrine in the adrenal medulla
Journal of Molecular Medicine (2021)
-
Metabolic Factors Determining the Susceptibility to Weight Gain: Current Evidence
Current Obesity Reports (2020)
-
Adrenomedullary function, obesity and permissive influences of catecholamines on body mass in patients with chromaffin cell tumours
International Journal of Obesity (2019)